Hittu Matta

Hittu Matta is an Associate Professor of Research Medicine at the Keck School of Medicine, University of Southern California (USC). She earned her Master's and PhD in Microbiology from an unspecified institution, followed by a fellowship at The Hamon Center for Therapeutic and Oncology Research, University of Texas Southwestern Medical Center. Her research focuses on Kaposi’s Sarcoma-Associated Herpesvirus (KSHV)-related malignancies and innovative drug development for cancer therapies.

Dr. Matta’s work spans virology, oncology, and immunology, with a strong emphasis on understanding KSHV pathogenesis and developing targeted therapies. She has collaborated extensively with co-authors like Preet Chaudhary, contributing to studies on viral proteins, NF-κB signaling pathways, and cytotoxicity assays. Her lab has pioneered novel luciferase-based assays for evaluating drug efficacy and CAR-T cell activity, advancing precision medicine approaches in oncology.

Her publications highlight contributions to primary effusion lymphoma research, HSP90 inhibitor mechanisms, and the role of viral oncogenes like vFLIP in tumor promotion. While no specific awards or grants are noted, her work is widely cited in virology and oncology fields, reflecting her significant impact on translational cancer research.